化物在癌症治疗中:向瘤微环境和转移信号通路
Raoufeh Koochaki1, Elaheh Amini2, Sara Zarehossini3
1Department of Cell & Molecular Biology, Faculty of Biological Sciences, Kharazmi University, Tehran, Iran.
Fitoterapia
|September 29, 2024
概括
来自植物的类化合物通过向多个细胞机制和克服抵抗,在癌症治疗中显示出显著的潜力. 本综述详细介绍了它们的抗癌性质,分子作用和传递增强措施,以提高有效性.
科学领域:
- 植物医学 植物医学
- 自然产品化学 自然产品化学
- 癌症生物学 癌症生物学
背景情况:
- 植物医学,利用植物衍生化合物,是癌症研究的一个快速发展的领域.
- 类化合物是一类天然产品,在癌症治疗和管理方面表现出巨大的潜力.
- 它们的多重准能力对抗癌症抵抗机制具有优势.
研究的目的:
- 为提供具有抗癌性质的自然存在的类化合物的全面概述.
- 强调其抗癌作用背后的分子机制.
- 讨论提高类化合物的生物利用率的策略,并确定新型候选物.
主要方法:
- 对类化合物的抗癌性质和分子机制的文献综述.
- 探索基于纳米载体的策略,以改善物理化学性质和生物可用性.
- 在临床试验中包括有关新发现的类化合物的信息.
- 简要提及高通量选和分子动力学,以加速发现.
主要成果:
- 类化合物向癌症进展中的关键细胞机制,包括亡诱导 (例如,柏柏林) 和血管生成抑制 (例如,).
- 它们通过调节转移相关的信号通路,如上皮细胞-介质细胞过渡来表现出抗增殖和抗癌作用.
- 纳米载体系统可以增强具有具有挑战性的物理化学性质的类化合物的系统生物可用性.
- 新型类化合物正在临床试验中进行研究,先进的选方法有助于识别.
结论:
- 自然存在的类化合物是具有多种分子机制的抗癌剂的有希望的来源.
- 改善它们的输送和生物可用性的策略对于临床转化至关重要.
- 目前正在进行的研究和先进的查技术正在加速发现基于类化合物的强效癌症疗法.
相关概念视频
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Non-Canonical Wnt Signaling Pathways
7.2K
Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
7.2K
Drugs that Destabilize Microtubules
1.9K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
1.9K
Canonical Wnt Signaling Pathway
8.7K
The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
8.7K


